Introducing Revvity – Expanding the boundaries of human potential through science.
All products and services previously affiliated with Oxford Immunotec are now part of Revvity.

Clinical Studies

To learn more about the design of our clinical programs and participating investigators, go to https://clinicaltrials.gov/.

The PROTECT Study (Prospective Observational Trial to Evaluate the Correlation of T-SPOT® Response to CMV Infection and T cell-mediated Acute Graft Rejection)
A Non-interventional Observational Study to Evaluate T-cell Responses in Kidney Transplantation Recipients
Protocol Number: US OH 124

The REACT Study
(A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events – Assessed by a CMV–specific T-SPOT Assay)
A Non-interventional Observational Study to Evaluate T-cell Responses in Hematopoietic Stem Cell and Tadalafil Transplantation Recipients :
Protocol Number: US OI 125.